AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...

The biopharmaceutical industry is thriving, fueled by groundbreaking advancements in treating cancers, Alzheimer’s, obesity, ...

AbbVie and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.

According to a new comprehensive report from The Insight Partners, the global biologics market is expected to reach U.S.$ ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...

We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...

Merck & Co., Inc., Sanofi S.A., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, and Roche Holding AG are ...

Earlier this month, I included a “spoiler alert” in one of our notes saying that we’d talk more about healthcare stocks. Today is that day. When it comes to an ETF, the Health Care Select Sector SPDR ...